2020 FEB 18 (NewsRx) -- By a
Financial supporters for this research include
The news reporters obtained a quote from the research from the
According to the news reporters, the research concluded: “Quantifying a more comprehensive taxonomy of PCV’s benefits will help to address potential undervaluation and may be sufficient not only to justify recommendation and reimbursement but also to stimulate efforts and investment toward closing coverage gaps.”
For more information on this research see: Commentary: Why Has Uptake of Pneumococcal Vaccines for Children Been so Slow? the Perils of Undervaluation.
Our news correspondents report that additional information may be obtained by contacting
The direct object identifier (DOI) for that additional information is: https://doi.org/10.1097/INF.0000000000002521. This DOI is a link to an online electronic document that is either free or for purchase, and can be your direct source for a journal article and its citation.
(Our reports deliver fact-based news of research and discoveries from around the world.)